The Recall Desk
HighFDA (Drugs)·D-1468-2019·Announced 2019-07-17

Testosterone Cypionate Injection Recalled for Lack of Sterility Assurance

First Pharma Associates is recalling Testosterone Cypionate 100 mg/mL injections due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a high-risk hazard (lack of sterility assurance for an injectable drug) where injury has not yet been reported, fitting the 'High' severity criteria.

Plain-English summary

First Pharma Associates LLC dba Riverpoint Pharmacy is recalling Testosterone Cypionate 100 mg/mL Sesame Oil Injection, 12mL vials. The recall is being conducted because of a lack of assurance of sterility for the product.

The affected product is prescription-only and was distributed in Idaho and Washington. Specific lot numbers and expiration dates are listed in the recall documentation. The source text does not report any illnesses or injuries associated with this recall.

Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
Testosterone Cypionate 100 mg/mL Sesame Oil Injection, 12mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot #: 04192019@1
  • Exp. 07/21/2019
  • 05312019@4
  • Exp. 09/03/2019

Distribution

Distributed in 2 states:

Part of a larger recall action

This product is one of 18 recalled by First Pharma Associates LLC dba Riverpoint Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 18 products in this recall →